Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation. / Taaning, E; Jacobsen, N; Morling, N.
In: British Journal of Haematology, Vol. 86, No. 3, 1994, p. 651-3.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation
AU - Taaning, E
AU - Jacobsen, N
AU - Morling, N
N1 - Keywords: Antigens, Human Platelet; Blood Platelets; Bone Marrow Transplantation; Humans; Immunoglobulin G; Leukemia, Myeloid, Acute; Male; Middle Aged; Platelet Count; Platelet Transfusion; Transplantation, Homologous
PY - 1994
Y1 - 1994
N2 - We report on a male who received a bone-marrow allograft from his HLA identical sister for acute myelogenous leukaemia. After transplantation, the patient suffered from refractoriness to the transfusions of HLA-matched platelets and a strong platelet-specific antibody, anti-HPA-2b, of IgG1 subclass was demonstrated in the patient's serum. In the serum of the bone-marrow donor a weak IgG1 anti-HPA-2b was demonstrated. IgG allotyping of the patient and donor showed identical results. We could not determine the origin of the anti-HPA-2b, although we hypothesize that the anti-HPA-2b was produced by immunocompetent donor lymphocytes infused with the suspension of bone-marrow cells.
AB - We report on a male who received a bone-marrow allograft from his HLA identical sister for acute myelogenous leukaemia. After transplantation, the patient suffered from refractoriness to the transfusions of HLA-matched platelets and a strong platelet-specific antibody, anti-HPA-2b, of IgG1 subclass was demonstrated in the patient's serum. In the serum of the bone-marrow donor a weak IgG1 anti-HPA-2b was demonstrated. IgG allotyping of the patient and donor showed identical results. We could not determine the origin of the anti-HPA-2b, although we hypothesize that the anti-HPA-2b was produced by immunocompetent donor lymphocytes infused with the suspension of bone-marrow cells.
M3 - Journal article
C2 - 8043449
VL - 86
SP - 651
EP - 653
JO - British Journal of Haematology
JF - British Journal of Haematology
SN - 0007-1048
IS - 3
ER -
ID: 16186154